These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 12496369)
21. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells. Miettinen S; Ahonen MH; Lou YR; Manninen T; Tuohimaa P; Syvälä H; Ylikomi T Int J Cancer; 2004 Jan; 108(3):367-73. PubMed ID: 14648702 [TBL] [Abstract][Full Text] [Related]
22. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3). Chen ML; Ray S; Swamy N; Holick MF; Ray R Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974 [TBL] [Abstract][Full Text] [Related]
23. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. Kemmis CM; Salvador SM; Smith KM; Welsh J J Nutr; 2006 Apr; 136(4):887-92. PubMed ID: 16549446 [TBL] [Abstract][Full Text] [Related]
24. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. Zehnder D; Bland R; Chana RS; Wheeler DC; Howie AJ; Williams MC; Stewart PM; Hewison M J Am Soc Nephrol; 2002 Mar; 13(3):621-629. PubMed ID: 11856765 [TBL] [Abstract][Full Text] [Related]
26. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549 [TBL] [Abstract][Full Text] [Related]
27. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Somjen D; Weisman Y; Kohen F; Gayer B; Limor R; Sharon O; Jaccard N; Knoll E; Stern N Circulation; 2005 Apr; 111(13):1666-71. PubMed ID: 15795327 [TBL] [Abstract][Full Text] [Related]
28. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Evans KN; Nguyen L; Chan J; Innes BA; Bulmer JN; Kilby MD; Hewison M Biol Reprod; 2006 Dec; 75(6):816-22. PubMed ID: 16957024 [TBL] [Abstract][Full Text] [Related]
29. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853 [TBL] [Abstract][Full Text] [Related]
30. Newly established assay method for 25-hydroxyvitamin D3 24-hydroxylase revealed much lower Km for 25-hydroxyvitamin D3 than for 1alpha,25-dihydroxyvitamin D3. Taniguchi T; Eto TA; Shiotsuki H; Sueta H; Higashi S; Iwamura T; Okuda KI; Setoguchi T J Bone Miner Res; 2001 Jan; 16(1):57-62. PubMed ID: 11149490 [TBL] [Abstract][Full Text] [Related]
31. Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Naja RP; Dardenne O; Arabian A; St Arnaud R Endocrinology; 2009 Sep; 150(9):4024-32. PubMed ID: 19477943 [TBL] [Abstract][Full Text] [Related]
32. Wavelength-dependent induction of CYP24A1-mRNA after UVB-triggered calcitriol synthesis in cultured human keratinocytes. Bär M; Domaschke D; Meye A; Lehmann B; Meurer M J Invest Dermatol; 2007 Jan; 127(1):206-13. PubMed ID: 16902422 [TBL] [Abstract][Full Text] [Related]
33. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Itin PH; Pittelkow MR; Kumar R Endocrinology; 1994 Nov; 135(5):1793-8. PubMed ID: 7956903 [TBL] [Abstract][Full Text] [Related]
34. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Murayama A; Takeyama K; Kitanaka S; Kodera Y; Kawaguchi Y; Hosoya T; Kato S Endocrinology; 1999 May; 140(5):2224-31. PubMed ID: 10218975 [TBL] [Abstract][Full Text] [Related]
35. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559 [TBL] [Abstract][Full Text] [Related]
36. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Fu GK; Lin D; Zhang MY; Bikle DD; Shackleton CH; Miller WL; Portale AA Mol Endocrinol; 1997 Dec; 11(13):1961-70. PubMed ID: 9415400 [TBL] [Abstract][Full Text] [Related]
37. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. van Driel M; Koedam M; Buurman CJ; Hewison M; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP FASEB J; 2006 Nov; 20(13):2417-9. PubMed ID: 17023519 [TBL] [Abstract][Full Text] [Related]